APA (7th ed.) Citation

Dai, X., Dai, X., Li, Z., Chen, S., Huang, Y., Ling, S., . . . Wang, Q. Preclinical efficacy and safety evaluation of BD211 autologous CD34+ hematopoietic stem cell injection for transfusion-dependent β-thalassemia in NCG-X mice. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Dai, Xuedong, Xuedong Dai, Zike Li, Shuang Chen, Ying Huang, Sikai Ling, Quanjun Wang, and Qi Wang. Preclinical Efficacy and Safety Evaluation of BD211 Autologous CD34+ Hematopoietic Stem Cell Injection for Transfusion-dependent β-thalassemia in NCG-X Mice. Frontiers Media S.A.

MLA (9th ed.) Citation

Dai, Xuedong, et al. Preclinical Efficacy and Safety Evaluation of BD211 Autologous CD34+ Hematopoietic Stem Cell Injection for Transfusion-dependent β-thalassemia in NCG-X Mice. Frontiers Media S.A.